She began in pharmaceutical sales, learned to make complicated businesses legible, and helped reclaim an agency after a merger went wrong. Today, Judy Capano runs Calcium+Company with the same preference for clarity over theater.

He started in advertising as a teenager, built Evoke from digital-first roots, and spent two decades turning specialist pieces into one global healthcare agency. The revealing part is not the scale. It is his insistence that the work stays human.

He spent two decades making medical education run on detail, trust and a home-grown platform. Then Adam Margolis sold L&M Healthcare Communications and learned how to trade independence for a larger field of play.
Pavone Group's bet is that a holding company can behave like a neighborhood agency: nine specialist shops, one shared bench, and a bulldog that doubles as an operating philosophy.
Spectrum Science began with a narrow conviction: complicated medicine deserves clear storytelling. Three decades and a run of acquisitions later, the more interesting product is the machinery behind the message.
Brogan & Partners built a business around messages people would rather avoid. Its trick is not louder advertising, but research precise enough to discover why an audience has stopped listening.
Michelle Adams built a Columbus agency one cold call at a time. Thirty years later, its best work still begins with the unfashionable question most marketers skip: what problem are we actually solving?
Austin Williams sells advertising, but its most persuasive product is proof: deposits, appointments, applications and enrollment. On Long Island, an independent agency built a national portfolio by insisting that the creative work answer to the spreadsheet.
SIMPSON Healthcare built a business in the narrow gap between discovering a therapy and making its science understood. Inside IQVIA, that small Connecticut agency now has a much larger map.
Imre spent three decades learning what people do when the decision feels personal. Now the independent agency is betting that empathy, performance data and AI visibility belong in the same room.
L&M built a business around the least glamorous parts of pharmaceutical education - contracts, dinner limits, speaker training, audit trails - then made the machinery valuable enough for Fingerpaint Group to buy it.
Inizio Evoke spent years collecting specialist agencies. Then it made the unusual admission that the collection had become the problem - and began turning a maze of names into one healthcare commercialization machine.
For nearly five decades, this Ybor City agency has done something harder than making ads: it has turned local identity into measurable action, from stadium seats to patient visits to a food bank reborn as a hub of opportunity.
Calcium+Company built a health-marketing group around a surprisingly sticky idea: brands, like bodies, need more than one nutrient. The interesting part is not the pun. It is the operating model hiding underneath it.
Star Group sold a seductive idea: the best agency should solve more than the ad. For 30 years it kept widening the assignment - until the machinery built for growth met a cash crisis it could not out-create.
Adams & Knight found a cheaper way to market a small state: pick a fight people already wanted to have, then give the argument somewhere to go.
LT has spent six decades selling attention. Its more useful talent is knowing when another ad, another click, or another line of code will not help.
The Nashville agency treats healthcare marketing less like a funnel and more like a signal problem. Its answer is to fix the plumbing, sharpen the story, and make every channel carry the same idea.
Snow Companies built a healthcare agency around a stubborn idea: a patient story is not raw material to be extracted, polished and forgotten. It is a relationship - and, in regulated medicine, the relationship is the product.
SFC Group built a virtual healthcare agency around a small bet: regulated work does not have to sound institutional. A one-eyed mammogram mascot shows what happens when strategy, wit, and medical guardrails share the same room.
Three men named Mealey and Hawkins built an agency from their middle names. Fifty-four years later, the disappearing act still explains how AB&C gets attention - by making the client the most interesting person in the room.
JPA Health began with an unfashionable idea: healthcare messages work better when the people who understand policy, patients, science and data sit at the same table. Then it spent two years buying the chairs it was missing.
Real Chemistry began as one consultant with a healthcare Rolodex. A bruising 2008 taught it a stranger lesson: when clients need several kinds of expertise at once, the agency itself has to become a portfolio.
For three decades, Merritt Group has made a business of translating dense technology into stories that buyers can repeat. The trick is not louder marketing. It is knowing exactly which details deserve a microphone.
ConcentricLife discovered that the weak point in pharmaceutical advertising was not the advertisement. It was everything around it - the patient, the prescriber, the data, the access and the organization expected to make them agree.
JPL started with video cameras in Harrisburg. Thirty-seven years later, it sells a more useful skill: knowing when the story needs a website, a stage, a search strategy - or all three at once.
A health campaign has to satisfy the scientist, the regulator, the payer, the physician, the patient, and the person scrolling at lunch. Ogilvy Health built one company to keep all six in the room.
Impact Communication Partners has spent more than four decades translating complicated science for healthcare professionals. Its sharpest idea is also its simplest: the best answer may arrive after the meeting is over.
A private-equity transition dented revenue. RevHealth's answer was not a louder campaign, but a quieter reinvention of the agency workflow - putting medical, access, creative and AI in the same room before the brief hardens.
The West Chester agency built two businesses around one stubborn problem: good science is useless if nobody can understand, approve, or act on it.